{"prompt": "['InterStim Amplitude Clinical Investigation Plan', 'MDT17030', 'Version 2.0', 'Page 36 of 61', 'Medtronic', 'If a subject learns or suspects that she is pregnant, the investigator will instruct her to turn her', 'neurostimulator OFF and to visit the study site as soon as possible; however, this will not be considered', 'a reportable AE.', '10.2. Potential Benefits', 'Subjects may not receive any direct medical benefit from participation in this study but subjects will', 'receive additional medical oversight of treatment. Participation in this study may not provide greater', 'benefit than if the subject was receiving InterStim Therapy outside of the study, as required study', 'programming is within approved programming specifications. Information from this study might help', 'researchers further understand InterStim Therapy related to uncomfortable stimulation. The benefit to', 'subjects participating in this study, and to future patients, resides in the knowledge gained from this', 'study.', '10.3. Risk-Benefit Rationale', 'Participation in this study will not expose the subject to greater risks than if he/she were receiving', 'InterStim Therapy outside of the study. There might be other discomforts and risks related to InterStim', 'Therapy and/or this study that are not foreseen at this time. In addition, based on the amplitude', 'settings, subjects may experience less than desired improvements in OAB symptoms.', 'The risks associated with InterStim II System are minimized in this study by selecting only qualified', 'Investigators experienced in InterStim Therapy, selecting an appropriate patient population via', 'inclusion/exclusion screening, and monitoring subject progress and events reported for this study. The', 'review and minimization of the potential risks to the patient and the potential benefits to the patient', 'support the conduct of this study.', '11. Adverse Events and Device Deficiencies', '11.1. Definitions/Classifications', 'Any adverse event meeting the definition of: serious, device related, therapy related and/or procedure', 'related as well as all device deficiencies will be considered reportable for this study. The term', '\"investigational device\" is part of ISO14155 definitions. The term \"investigational device\" refers to any', 'device used in the study including market released devices. Adverse events and device deficiencies are', 'defined as follows:', 'Medtronic Confidential', '056-F275, v3.0 Clinical Investigation Plan Template']['InterStim Amplitude Clinical Investigation Plan', 'MDT17030', 'Version 2.0', 'Page 37 of 61', 'Medtronic', 'Device Related: An adverse event that results from the presence or performance (intended or', 'otherwise) of the InterStim II System', 'Procedure Related: An adverse event that occurs due to any procedure related to the', 'implantation or surgical modification of the InterStim Il System. The procedure is defined as the', 'lead placement or implant procedure.', 'Therapy Related: An adverse event related to therapy delivery by device e.g. device stimulation', 'issue (normally therapy-related events resolve when the device is turned off or reprogrammed).', 'Table 11-1: Adverse Event & Device Deficiency Definitions', 'Term', 'General', 'Adverse Event (AE)', 'Any untoward medical occurrence, unintended disease or injury, or untoward', 'clinical signs (including abnormal laboratory findings) in subjects, users or other', '(ISO 14155:2011', 'persons, whether or not related to the investigational medical device.', '3.2)', 'NOTE 1 This definition includes events related to the investigational medical', 'device or the comparator.', 'NOTE 2 This definition includes events related to the procedures involved.', 'NOTE 3 For users or other persons, this definition is restricted to events related', 'to investigational medical devices.', 'Adverse Device', 'Adverse event related to the use of an investigational medical device.', 'Effect (ADE)', 'NOTE 1 This definition includes adverse events resulting from insufficient or', '(ISO 14155:2011', 'inadequate instructions for use, deployment, implantation, installation, or', '3.1)', 'operation, or any malfunction of the investigational medical device.', 'NOTE 2 This definition includes any event resulting from use error or from', 'intentional misuse of the investigational medical device.', 'Device Deficiency', 'Inadequacy of a medical device with respect to its identity, quality, durability,', '(DD) *', 'reliability, safety or performance.', 'NOTE 1 Device deficiencies include malfunctions, use errors, and inadequate', '(ISO 14155:2011', 'labeling.', '3.15)', 'Malfunction: Failure of an investigational medical device to perform in', '(ISO 14155:2011', 'accordance with its intended purpose when used in accordance with the', '3.27)', 'instructions for use or CIP', 'Medtronic Confidential', '056-F275, v3.0 Clinical Investigation Plan Template']\n\n###\n\n", "completion": "END"}